Literature DB >> 3208532

A kallikrein-like molecule and plasma vasoactivity in minimal change disease. Increased turnover in relapse versus remission.

W W Bakker1, J F Baller, W H van Luijk.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 3208532

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN： 0302-5144            Impact factor:   1.580


× No keyword cloud information.
  8 in total

Review 1.  Pathogenesis of proteinuria in idiopathic minimal change disease: molecular mechanisms.

Authors:  Gabriel Cara-Fuentes; William L Clapp; Richard J Johnson; Eduardo H Garin
Journal:  Pediatr Nephrol       Date:  2016-07-06       Impact factor: 3.714

Review 2.  Do circulating factors play a role in the pathogenesis of minimal change nephrotic syndrome?

Authors:  W W Bakker; W H van Luijk
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

Review 3.  An alternative view of the proposed alternative activities of hemopexin.

Authors:  Marcia R Mauk; Ann Smith; A Grant Mauk
Journal:  Protein Sci       Date:  2011-03-30       Impact factor: 6.725

4.  Altered activity of plasma hemopexin in patients with minimal change disease in relapse.

Authors:  Winston W Bakker; Catharina M L van Dael; Leonie J W M Pierik; Joanna A E van Wijk; Jeroen Nauta; Theo Borghuis; Jola J Kapojos
Journal:  Pediatr Nephrol       Date:  2005-08-04       Impact factor: 3.714

5.  Hemopexin induces nephrin-dependent reorganization of the actin cytoskeleton in podocytes.

Authors:  Rachel Lennon; Anurag Singh; Gavin I Welsh; Richard J Coward; Simon Satchell; Lan Ni; Peter W Mathieson; Winston W Bakker; Moin A Saleem
Journal:  J Am Soc Nephrol       Date:  2008-08-27       Impact factor: 10.121

6.  Overexpression of hemopexin in the diabetic eye: a new pathogenic candidate for diabetic macular edema.

Authors:  Cristina Hernández; Marta Garcia-Ramírez; Rafael Simó
Journal:  Diabetes Care       Date:  2013-04-25       Impact factor: 19.112

7.  Immunoglobulin E and G Levels in Predicting Minimal Change Disease before Renal Biopsy.

Authors:  Ching-Chung Hsiao; Kun-Hua Tu; Chun-Yih Hsieh; Cheng-Chia Lee; Chih-Hsiang Chang; Pei-Chun Fan; Ya-Chung Tian; Ji-Tseng Fang
Journal:  Biomed Res Int       Date:  2018-11-11       Impact factor: 3.411

Review 8.  New Insights into Treating Early and Advanced Stage Diabetic Retinopathy.

Authors:  Rafael Simó; Cristina Hernández
Journal:  Int J Mol Sci       Date:  2022-07-31       Impact factor: 6.208
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.